EI
CPHI icon

EFG International’s China Pharma Holdings CPHI Stock Holding History

EFG International’s Portfolio CPHI Stock Details CPHI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$24 Hold
40
– – ﹤0.01% 1038
2025
Q4 		$48 Buy
+40
New +$66 ﹤0.01% 868

Other funds holding CPHI

Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
DB
Danske Bank Copenhagen K, Denmark $41.5B AUM 29.19% 1-Year Est. Return

EFG International's CPHI Position: Q1 2026 in Review

EFG International held its China Pharma Holdings (CPHI) position steady in Q1 2026 at 40 shares worth $24. The position accounts for ﹤0.01% of the portfolio, ranked #1038.

EFG International first reported a position in CPHI in Q4 2025 and has held it in 2 quarters since. The position peaked at $48 in Q4 2025. 6 funds tracked by Wall St. Rank hold CPHI as of Q1 2026.

  • EFG International held 40 shares of China Pharma Holdings worth $24 as of Q1 2026.
  • EFG International left its China Pharma Holdings share count unchanged in Q1 2026.
  • China Pharma Holdings made up ﹤0.01% of EFG International's portfolio in Q1 2026, its #1038 holding.
  • EFG International first reported a position in China Pharma Holdings in Q4 2025 and has held it in 2 quarters since.
  • EFG International's China Pharma Holdings position peaked at $48 in Q4 2025.
  • 6 funds tracked by Wall St. Rank held China Pharma Holdings as of Q1 2026.

Based on EFG International's 13F filing for Q1 2026, filed 15 May 2026.